These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22386665)

  • 41. Synthesis and biological evaluation of picolinamides and thiazole-2-carboxamides as mGluR5 (metabotropic glutamate receptor 5) antagonists.
    Vu HN; Kim JY; Hassan AH; Choi K; Park JH; Park KD; Lee JK; Pae AN; Choo H; Min SJ; Cho YS
    Bioorg Med Chem Lett; 2016 Jan; 26(1):140-4. PubMed ID: 26598462
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fluorinated 9H-xanthene-9-carboxylic acid oxazol-2-yl-amides as potent, orally available mGlu1 receptor enhancers.
    Vieira E; Huwyler J; Jolidon S; Knoflach F; Mutel V; Wichmann J
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1666-9. PubMed ID: 19233648
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of (R)-1-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)urea (ABT-102) as a potent TRPV1 antagonist for pain management.
    Gomtsyan A; Bayburt EK; Schmidt RG; Surowy CS; Honore P; Marsh KC; Hannick SM; McDonald HA; Wetter JM; Sullivan JP; Jarvis MF; Faltynek CR; Lee CH
    J Med Chem; 2008 Feb; 51(3):392-5. PubMed ID: 18183945
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discovery, Structure-Activity Relationship, and Biological Characterization of a Novel Series of 6-((1 H-Pyrazolo[4,3- b]pyridin-3-yl)amino)-benzo[ d]isothiazole-3-carboxamides as Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 4 (mGlu
    Bollinger SR; Engers DW; Panarese JD; West M; Engers JL; Loch MT; Rodriguez AL; Blobaum AL; Jones CK; Thompson Gray A; Conn PJ; Lindsley CW; Niswender CM; Hopkins CR
    J Med Chem; 2019 Jan; 62(1):342-358. PubMed ID: 30247901
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of orally bioavailable and CNS penetrant biphenylaminocyclopropane carboxamide bradykinin B1 receptor antagonists.
    Kuduk SD; Di Marco CN; Chang RK; Wood MR; Schirripa KM; Kim JJ; Wai JM; DiPardo RM; Murphy KL; Ransom RW; Harrell CM; Reiss DR; Holahan MA; Cook J; Hess JF; Sain N; Urban MO; Tang C; Prueksaritanont T; Pettibone DJ; Bock MG
    J Med Chem; 2007 Jan; 50(2):272-82. PubMed ID: 17228869
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fused tricyclic mGluR1 antagonists for the treatment of neuropathic pain.
    Bennett CE; Burnett DA; Greenlee WJ; Knutson CE; Korakas P; Li C; Tulshian D; Wu WL; Bertorelli R; Fredduzzi S; Grilli M; Lozza G; Reggiani A; Veltri A
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1575-8. PubMed ID: 22266036
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The peripheral role of group I metabotropic glutamate receptors on nociceptive behaviors in rats with knee joint inflammation.
    Lee KS; Kim J; Yoon YW; Lee MG; Hong SK; Han HC
    Neurosci Lett; 2007 Apr; 416(2):123-7. PubMed ID: 17314010
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 2-Nitrophenylcarbamoyl-(S)-prolyl-(S)-3-(2-naphthyl)alanyl-N-benzyl-N - methylamide (SDZ NKT 343), a potent human NK1 tachykinin receptor antagonist with good oral analgesic activity in chronic pain models.
    Walpole C; Ko SY; Brown M; Beattie D; Campbell E; Dickenson F; Ewan S; Hughes GA; Lemaire M; Lerpiniere J; Patel S; Urban L
    J Med Chem; 1998 Aug; 41(17):3159-73. PubMed ID: 9703462
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis of 2,5-thiazole butanoic acids as potent and selective alpha(v)beta3 integrin receptor antagonists with improved oral pharmacokinetic properties.
    Wendt JA; Wu H; Stenmark HG; Boys ML; Downs VL; Penning TD; Chen BB; Wang Y; Duffin T; Finn MB; Keene JL; Engleman VW; Freeman SK; Hanneke ML; Shannon KE; Nickols MA; Steininger CN; Westlin M; Klover JA; Westlin W; Nickols GA; Russell MA
    Bioorg Med Chem Lett; 2006 Feb; 16(4):845-9. PubMed ID: 16303301
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discovery and biological profile of 4-(1-aryltriazol-4-yl)-tetrahydropyridines as an orally active new class of metabotropic glutamate receptor 1 antagonist.
    Ito S; Satoh A; Nagatomi Y; Hirata Y; Suzuki G; Kimura T; Satow A; Maehara S; Hikichi H; Hata M; Kawamoto H; Ohta H
    Bioorg Med Chem; 2008 Nov; 16(22):9817-29. PubMed ID: 18849168
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discovery of orally efficacious tetracyclic metabotropic glutamate receptor 1 (mGluR1) antagonists for the treatment of chronic pain.
    Wu WL; Burnett DA; Domalski M; Greenlee WJ; Li C; Bertorelli R; Fredduzzi S; Lozza G; Veltri A; Reggiani A
    J Med Chem; 2007 Nov; 50(23):5550-3. PubMed ID: 17929793
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and SAR development of novel mGluR1 antagonists for the treatment of chronic pain.
    Brumfield S; Korakas P; Silverman LS; Tulshian D; Matasi JJ; Qiang L; Bennett CE; Burnett DA; Greenlee WJ; Knutson CE; Wu WL; Sasikumar TK; Domalski M; Bertorelli R; Grilli M; Lozza G; Reggiani A; Li C
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7223-6. PubMed ID: 23084894
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclohexenyl- and dehydropiperidinyl-alkynyl pyridines as potent metabotropic glutamate subtype 5 (mGlu5) receptor antagonists.
    Chua PC; Nagasawa JY; Bleicher LS; Munoz B; Schweiger EJ; Tehrani L; Anderson JJ; Cramer M; Chung J; Green MD; King CD; Reyes-Manalo G; Cosford ND
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4589-93. PubMed ID: 16115767
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective NR1/2B N-methyl-D-aspartate receptor antagonists among indole-2-carboxamides and benzimidazole-2-carboxamides.
    Borza I; Bozó E; Barta-Szalai G; Kiss C; Tárkányi G; Demeter A; Gáti T; Háda V; Kolok S; Gere A; Fodor L; Nagy J; Galgóczy K; Magdó I; Agai B; Fetter J; Bertha F; Keserü GM; Horváth C; Farkas S; Greiner I; Domány G
    J Med Chem; 2007 Mar; 50(5):901-14. PubMed ID: 17290978
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The identification of novel orally active mGluR5 antagonist GSK2210875.
    Pilla M; Andreoli M; Tessari M; Delle-Fratte S; Roth A; Butler S; Brown F; Shah P; Bettini E; Cavallini P; Benedetti R; Minick D; Smith P; Tehan B; D'Alessandro P; Lorthioir O; Ball C; Garzya V; Goodacre C; Watson S
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7521-4. PubMed ID: 21051228
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of Nitazoxanide as a Group I Metabotropic Glutamate Receptor Negative Modulator for the Treatment of Neuropathic Pain: An In Silico Drug Repositioning Study.
    Ai N; Wood RD; Welsh WJ
    Pharm Res; 2015 Aug; 32(8):2798-807. PubMed ID: 25762088
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Brain penetration, target engagement, and disposition of the blood-brain barrier-crossing bispecific antibody antagonist of metabotropic glutamate receptor type 1.
    Webster CI; Caram-Salas N; Haqqani AS; Thom G; Brown L; Rennie K; Yogi A; Costain W; Brunette E; Stanimirovic DB
    FASEB J; 2016 May; 30(5):1927-40. PubMed ID: 26839377
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel thienopyrimidinones as mGluR1 antagonists.
    Kim Y; Kim J; Kim S; Ki Y; Seo SH; Tae J; Ko MK; Jang HS; Lim EJ; Song C; Cho Y; Koh HY; Chong Y; Choo IH; Keum G; Min SJ; Choo H
    Eur J Med Chem; 2014 Oct; 85():629-37. PubMed ID: 25127154
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design and synthesis of noncompetitive metabotropic glutamate receptor subtype 5 antagonists.
    Kulkarni SS; Nightingale B; Dersch CM; Rothman RB; Newman AH
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3371-5. PubMed ID: 16678408
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.